Your shopping cart is currently empty

VGB4 is an antagonist peptide of VEGF-A and VEGF-B, replicating the two binding regions of VEGF-B (loop 1 and loop 3) and connecting them through the receptor binding region of VEGF-A (loop 3). VGB4 displays significant anti-angiogenic and anti-tumor activities, capable of modulating tumor growth and metastasis through various mechanisms. It can be utilized in anti-cancer research.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | VGB4 is an antagonist peptide of VEGF-A and VEGF-B, replicating the two binding regions of VEGF-B (loop 1 and loop 3) and connecting them through the receptor binding region of VEGF-A (loop 3). VGB4 displays significant anti-angiogenic and anti-tumor activities, capable of modulating tumor growth and metastasis through various mechanisms. It can be utilized in anti-cancer research. |
| Formula | C122H205N33O32S2 |
| Sequence | Lys-Gln-Leu-Val-Ile-Lys-Pro-His-Gly-Gln-Ile-Leu-Met-Ile-Arg-Tyr-Pro-Ser-Ser-Gln-Leu-Glu-Met |
| Sequence Short | KQLVIKPHGQILMIRYPSSQLEM |
| Storage | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.